Ultragenyx Pharmaceutical, Inc. (RARE)
15.43
-0.14
(-0.90%)
USD |
NASDAQ |
Nov 06, 16:00
15.42
-0.01
(-0.06%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Net Income (TTM) : -524.00M for Sept. 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | -524.00M |
| June 30, 2026 | -586.41M |
| March 31, 2026 | -609.36M |
| December 31, 2025 | -575.44M |
| September 30, 2025 | -579.83M |
| June 30, 2025 | -532.93M |
| March 31, 2025 | -549.58M |
| December 31, 2024 | -569.18M |
| September 30, 2024 | -558.99M |
| June 30, 2024 | -585.12M |
| March 31, 2024 | -613.35M |
| December 31, 2023 | -606.64M |
| September 30, 2023 | -635.28M |
| June 30, 2023 | -720.74M |
| March 31, 2023 | -719.07M |
| December 31, 2022 | -707.42M |
| September 30, 2022 | -678.05M |
| June 30, 2022 | -505.94M |
| March 31, 2022 | -470.20M |
| December 31, 2021 | -454.02M |
| September 30, 2021 | -355.58M |
| June 30, 2021 | -351.42M |
| March 31, 2021 | -203.68M |
| December 31, 2020 | -186.57M |
| September 30, 2020 | -256.36M |
| Date | Value |
|---|---|
| June 30, 2020 | -300.51M |
| March 31, 2020 | -425.00M |
| December 31, 2019 | -402.73M |
| September 30, 2019 | -396.75M |
| June 30, 2019 | -371.06M |
| March 31, 2019 | -324.62M |
| December 31, 2018 | -197.61M |
| September 30, 2018 | -191.52M |
| June 30, 2018 | -183.43M |
| March 31, 2018 | -203.60M |
| December 31, 2017 | -302.14M |
| September 30, 2017 | -291.70M |
| June 30, 2017 | -277.38M |
| March 31, 2017 | -261.41M |
| December 31, 2016 | -245.87M |
| September 30, 2016 | -229.81M |
| June 30, 2016 | -204.13M |
| March 31, 2016 | -177.00M |
| December 31, 2015 | -145.62M |
| September 30, 2015 | -107.14M |
| June 30, 2015 | -83.75M |
| March 31, 2015 | -67.55M |
| December 31, 2014 | -59.80M |
| September 30, 2014 | -54.38M |
| June 30, 2014 | -51.12M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Ionis Pharmaceuticals, Inc. | -564.78M |
| AbbVie, Inc. | 10.30B |
| Krystal Biotech, Inc. | 225.17M |
| BridgeBio Pharma, Inc. | -577.58M |
| Alnylam Pharmaceuticals, Inc. | 2.724B |